PHI with Intermittent claudication
How does this condition affect your private health insurance?
Schaufensterkrankheit, or intermittent claudication, is a symptom of Peripheral Artery Disease (PAD). It manifests as cramping, pain, or tiredness in the leg or hip muscles during physical activity, like walking, which typically subsides with rest. This occurs because narrowed arteries, often due to atherosclerosis, cannot deliver enough oxygenated blood to the muscles during exertion. While not directly life-threatening, it significantly impacts quality of life and is a strong indicator of widespread arterial disease, including an increased risk of heart attack and stroke. The name 'window-shopping disease' refers to the frequent stops individuals make due to pain.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 50%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
An episode of pain typically lasts minutes, resolving with rest. The underlying condition is chronic.
Duration of Illness (Lifetime)
Chronic disease, usually lifelong and progressive without intervention.
Cost of Treatment (Initial)
Initial diagnostic tests (e.g., ABI, Doppler ultrasound) and lifestyle counseling, potentially a few hundred to a couple of thousand USD/EUR.
Cost of Treatment (Lifetime)
Substantial, ranging from several thousand for long-term medication and monitoring, to tens of thousands for interventional procedures (angioplasty, stenting) or bypass surgery.
Mortality Rate
Not directly from claudication, but PAD significantly increases the risk of cardiovascular events (heart attack, stroke), which are leading causes of death (moderate to high risk of death from associated conditions over lifetime).
Risk of Secondary Damages
High. Untreated PAD can lead to critical limb ischemia (rest pain, non-healing ulcers), infection, gangrene, and amputation (10-30% risk over 5-10 years for limb-threatening events). Increased risk of cardiovascular events.
Probability of Full Recovery
Low to moderate. While symptoms can be managed and improved with lifestyle changes and treatment, complete reversal of underlying atherosclerosis is rare. The goal is symptom control and halting progression.
Underlying Disease Risk
High. Strongly associated with other cardiovascular risk factors and diseases, including hypertension (50-70%), diabetes (20-30%), hyperlipidemia (60-80%), and coronary artery disease (40-60%).